{"title":"The relationship between advanced glycation end products, metabolic metrics, HbA<sub>1c,</sub> and diabetic nephropathy.","authors":"Liping Xue, Yi Zhang, Qiu Zhang","doi":"10.3389/fendo.2025.1468737","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In this cross-sectional study, we aim to investigate the value of non-invasive advanced glycation end products (AGEs) detection in the early screening of diabetic nephropathy(DN) among individuals with type 2 diabetes mellitus and assess whether metabolic parameters and glycated hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) can moderate this relationship.</p><p><strong>Methods: </strong>A total of 912 T2DM patients were enrolled. The urinary albumin-to-creatinine ratio (UACR) was measured in morning urine samples to assess DN. AGEs were non-invasively measured through skin autofluorescence. Recognizing the role of age in both AGEs and DN, AGE<sub>age</sub> was calculated as AGEs × age/100 for related analyses.</p><p><strong>Results: </strong>The overall prevalence of DN in the present study was 37.2%. Elevated AGE<sub>age</sub>(χ<sup>2</sup> = 61.06) was associated with a higher prevalence of DN. Multivariable linear regression demonstrated that AGE<sub>age</sub> was positively associated with UACR levels(β = 0.154, 95% CI: 0.126, 0.306, P<0.001). In the moderation analysis, glycated hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) affected the correlation between AGE<sub>age</sub> and UACR. Body mass index (BMI) and triglyceride glucose-body mass index (TyG-BMI) also affect the correlation between AGE<sub>age</sub> and UACR, there were significant interactions between AGE<sub>age</sub>, HbA<sub>1c</sub>, BMI, TyG-BMI, and UACR.</p><p><strong>Conclusions: </strong>Complex associations and interactions were observed between AGEs, metabolic metrics, HbA<sub>1c</sub>, and DN. Implementing comprehensive interventions can potentially benefit the prevention of DN in T2DM patients.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"16 ","pages":"1468737"},"PeriodicalIF":3.9000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11925793/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fendo.2025.1468737","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: In this cross-sectional study, we aim to investigate the value of non-invasive advanced glycation end products (AGEs) detection in the early screening of diabetic nephropathy(DN) among individuals with type 2 diabetes mellitus and assess whether metabolic parameters and glycated hemoglobin A1c (HbA1c) can moderate this relationship.
Methods: A total of 912 T2DM patients were enrolled. The urinary albumin-to-creatinine ratio (UACR) was measured in morning urine samples to assess DN. AGEs were non-invasively measured through skin autofluorescence. Recognizing the role of age in both AGEs and DN, AGEage was calculated as AGEs × age/100 for related analyses.
Results: The overall prevalence of DN in the present study was 37.2%. Elevated AGEage(χ2 = 61.06) was associated with a higher prevalence of DN. Multivariable linear regression demonstrated that AGEage was positively associated with UACR levels(β = 0.154, 95% CI: 0.126, 0.306, P<0.001). In the moderation analysis, glycated hemoglobin A1c (HbA1c) affected the correlation between AGEage and UACR. Body mass index (BMI) and triglyceride glucose-body mass index (TyG-BMI) also affect the correlation between AGEage and UACR, there were significant interactions between AGEage, HbA1c, BMI, TyG-BMI, and UACR.
Conclusions: Complex associations and interactions were observed between AGEs, metabolic metrics, HbA1c, and DN. Implementing comprehensive interventions can potentially benefit the prevention of DN in T2DM patients.
期刊介绍:
Frontiers in Endocrinology is a field journal of the "Frontiers in" journal series.
In today’s world, endocrinology is becoming increasingly important as it underlies many of the challenges societies face - from obesity and diabetes to reproduction, population control and aging. Endocrinology covers a broad field from basic molecular and cellular communication through to clinical care and some of the most crucial public health issues. The journal, thus, welcomes outstanding contributions in any domain of endocrinology.
Frontiers in Endocrinology publishes articles on the most outstanding discoveries across a wide research spectrum of Endocrinology. The mission of Frontiers in Endocrinology is to bring all relevant Endocrinology areas together on a single platform.